CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 279 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,258 | +42.3% | 100,276 | +10.3% | 7.71% | +36.9% |
| Q1 2024 | $2,289 | +90.0% | 90,876 | +145.0% | 5.64% | +91.3% |
| Q4 2023 | $1,205 | +17.7% | 37,091 | -1.3% | 2.95% | +0.7% |
| Q3 2023 | $1,024 | +29.5% | 37,569 | +5.7% | 2.92% | +36.8% |
| Q2 2023 | $791 | +2.7% | 35,539 | 0.0% | 2.14% | -4.4% |
| Q1 2023 | $770 | +6.6% | 35,539 | 0.0% | 2.24% | -2.4% |
| Q4 2022 | $722 | -99.9% | 35,539 | 0.0% | 2.29% | -15.7% |
| Q3 2022 | $911,000 | +7.8% | 35,539 | 0.0% | 2.72% | -1.1% |
| Q2 2022 | $845,000 | -4.5% | 35,539 | -9.5% | 2.75% | +53.8% |
| Q1 2022 | $885,000 | +13.2% | 39,289 | -0.6% | 1.79% | +20.3% |
| Q4 2021 | $782,000 | -0.8% | 39,519 | -1.3% | 1.49% | +32.2% |
| Q3 2021 | $788,000 | -10.6% | 40,044 | 0.0% | 1.12% | -5.5% |
| Q2 2021 | $881,000 | -7.6% | 40,044 | 0.0% | 1.19% | -1.6% |
| Q1 2021 | $953,000 | -9.2% | 40,044 | -0.3% | 1.21% | -48.1% |
| Q4 2020 | $1,050,000 | +49.6% | 40,154 | -0.4% | 2.33% | +6.0% |
| Q3 2020 | $702,000 | -32.5% | 40,314 | -34.8% | 2.20% | -31.8% |
| Q2 2020 | $1,040,000 | +33.3% | 61,854 | -5.7% | 3.22% | -5.6% |
| Q1 2020 | $780,000 | -7.5% | 65,609 | -5.8% | 3.41% | +27.7% |
| Q4 2019 | $843,000 | -19.6% | 69,649 | -6.1% | 2.67% | -21.0% |
| Q3 2019 | $1,048,000 | +22.3% | 74,139 | -3.5% | 3.38% | +28.9% |
| Q2 2019 | $857,000 | -8.2% | 76,824 | -3.5% | 2.63% | -6.7% |
| Q1 2019 | $934,000 | -20.6% | 79,574 | -9.6% | 2.82% | -24.7% |
| Q4 2018 | $1,176,000 | -4.9% | 88,004 | -0.2% | 3.74% | +30.2% |
| Q3 2018 | $1,236,000 | -10.8% | 88,154 | 0.0% | 2.87% | -13.6% |
| Q2 2018 | $1,386,000 | -41.7% | 88,154 | -39.0% | 3.32% | -41.6% |
| Q1 2018 | $2,379,000 | -6.1% | 144,602 | +3.1% | 5.69% | -1.7% |
| Q4 2017 | $2,533,000 | -6.2% | 140,282 | +0.3% | 5.78% | -3.9% |
| Q3 2017 | $2,699,000 | +64.1% | 139,867 | +0.3% | 6.02% | +59.7% |
| Q2 2017 | $1,645,000 | +75.2% | 139,397 | +62.6% | 3.77% | +82.1% |
| Q1 2017 | $939,000 | +48.1% | 85,705 | -1.8% | 2.07% | +39.5% |
| Q4 2016 | $634,000 | – | 87,315 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,360,485 | $186,021 | 8.91% |
| Novo Holdings A/S | 3,377,768 | $75,155,338 | 5.81% |
| Parallel Advisors, LLC | 3,726,565 | $82,916,071 | 2.67% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $791 | 2.14% |
| S&T BANK/PA | 347,260 | $7,727 | 1.39% |
| FAS Wealth Partners, Inc. | 310,771 | $6,914,655 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,112,500 | 0.83% |
| Granite Investment Partners, LLC | 792,519 | $17,633,548 | 0.70% |
| Bridge City Capital, LLC | 60,632 | $1,349,062 | 0.64% |
| AJ WEALTH STRATEGIES, LLC | 509,934 | $11,346,032 | 0.55% |